Evidence map›Paper›PMID 33025335›Full record

ArticleAAPS PharmSciTech2020

Towards a Continuous Manufacturing Process of Protein-Loaded Polymeric Nanoparticle Powders.

Stefan Schiller, Andrea Hanefeld, Marc Schneider, Claus-Michael Lehr

Abstract read
In one paragraph

Article in AAPS PharmSciTech, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. How PLGA Microspheres are Emerging as a Key Drug Delivery System.International journal of nanomedicine · 2026
    Review
  2. Review
  3. Chitosan-Coated PLGA Nanoparticles Loaded withNanomaterials (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stefan SchillerDepartment of Pharmacy, Biopharmaceutics & Pharmaceutical Technology, Saarland University, Saarbrücken, Germany. stefan.schiller@merckgroup.com.
Andrea HanefeldGlobal Healthcare Operations Innovation Network, Merck Healthcare KGaA, Darmstadt, Germany.
Marc SchneiderDepartment of Pharmacy, Biopharmaceutics & Pharmaceutical Technology, Saarland University, Saarbrücken, Germany.
Claus-Michael LehrDepartment of Pharmacy, Biopharmaceutics & Pharmaceutical Technology, Saarland University, Saarbrücken, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To develop a scalable and efficient process suitable for the continuous manufacturing of poly(lactic-co-glycolic acid) (PLGA) nanoparticles containing ovalbumin as the model protein. PLGA nanoparticles were prepared using a double emulsification spray-drying method. Emulsions were prepared using a focused ultrasound transducer equipped with a flow cell. Either poly(vinyl alcohol) (PVA) or poloxamer 407 (P-407) was used as a stabilizer. Aliquots of the emulsions were blended with different matrix excipients and spray dried, and the yield and size of the resuspended nanoparticles was determined and compared against solvent displacement. Nanoparticle sizes of spray-dried PLGA/PVA emulsions were independent of the matrix excipient and comparable with sizes from the solvent displacement method. The yield of the resuspended nanoparticles was highest for emulsions containing trehalose and leucine (79%). Spray drying of PLGA/P-407 emulsions led to agglomerated nanoparticles independent of the matrix excipient. PLGA/P-407 nanoparticles pre-formed by solvent displacement could be spray dried with limited agglomeration when PVA was added as an additional stabilizer. A comparably high and economically interesting nanoparticle yield could be achieved with a process suitable for continuous manufacturing. Further studies are needed to understand the robustness of a continuous process at commercial scale.

Indexed as

Drug CompoundingEmulsionsExcipientsNanoparticlesPolylactic Acid-Polyglycolic Acid CopolymerPowdersEmulsionsExcipientsPolylactic Acid-Polyglycolic Acid CopolymerPowderscontinuous manufacturingfocused ultrasoundPLGA nanoparticlesprotein deliveryspray drying

Identifiers

PMID33025335
PMCPMC7538403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.